Riskpilot← Back to searchSign inGet full accessCHEMVET PHARMA ApS
APSActiveCVR 20386908A.C.Illums Vej 6Wholesale of other food · NACE 4638Est. 19971 employees
Revenue 2024
DKK 1,5M
+64% vs 2023
EBITDA margin
68.2%
+133% vs 2023
Equity ratio
85.1%
Financial strength
Net profit 2024
DKK 808K
+56% vs 2023
| Revenue | DKK 1,5M | +64% |
| EBITDA | DKK 999K | +133% |
| Net profit | DKK 808K | +56% |
| Total assets | DKK 3,6M | -47% |
| Equity | DKK 3,1M | +35% |
| Employees | 1 | — |
Legal name
CHEMVET PHARMA ApS
CVR number
20386908
Legal form
Anpartsselskab
NACE code
4638 · Wholesale of other food
Founded
15. juni 1997
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller direktionen.
Company purpose
Selskabets formål er at drive handel og industri.
Address
A.C.Illums Vej 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 337 | 606 | 1.884 | 1.685 | 826 | 868 | 646 | 757 | 742 | 712 | 317 | 251 | 892 | 1.464 |
| Staff expenses | -0 | -237 | -579 | -608 | -299 | -751 | -729 | -730 | -761 | -705 | -802 | -554 | -463 | -465 |
| EBITDA | 337 | 369 | 1.305 | 1.076 | 527 | 118 | -83 | 27 | -18 | 7 | -486 | -303 | 428 | 999 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 337 | 369 | 1.305 | 1.076 | 527 | 118 | -83 | 27 | -18 | 7 | -486 | -303 | 428 | 999 |
| Net financials | -574 | -459 | -377 | -319 | -104 | -40 | 61 | -25 | 21 | 11 | 9 | -9 | 12 | 36 |
| Profit before tax | -237 | -90 | 928 | 758 | 424 | 78 | -22 | 2 | 3 | 18 | -477 | -312 | 440 | 1.035 |
| Tax | -59 | -22 | 229 | 178 | 93 | 17 | -5 | 0 | 1 | 4 | -0 | -0 | -77 | 228 |
| Net profit | -178 | -67 | 699 | 579 | 331 | 61 | -18 | 1 | 2 | 14 | -477 | -312 | 517 | 808 |
| Item | 2012 | 2013 | 2014 | 2015 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 19.626 | 12.718 | 11.892 | 9.797 | 6.924 | 4.203 | 3.515 | 3.272 | 3.410 | 3.670 | 2.811 | 2.334 | 6.835 | 3.647 |
| Equity | 1.273 | 1.206 | 1.904 | 2.484 | 2.815 | 2.876 | 2.858 | 2.549 | 2.552 | 2.566 | 2.089 | 1.778 | 2.294 | 3.102 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51 | 0 | 0 | 0 | 0 |
| Short-term debt | 18.353 | 11.512 | 9.988 | 7.313 | 4.109 | 1.327 | 657 | 723 | 858 | 1.053 | 722 | 556 | 4.541 | 545 |
| Total debt | 18.353 | 11.512 | 9.988 | 7.313 | 4.109 | 1.327 | 657 | 723 | 858 | 1.104 | 722 | 556 | 4.541 | 545 |
EBITDA margin
68.2%
This company
15.8%
Market median
+332% vs market
20122024
Equity ratio
85.1%
This company
38.2%
Market median
+123% vs market
20122024
Return on equity
26.0%
This company
18.4%
Market median
+41% vs market
20122024
Net profit margin
55.1%
This company
8.1%
Market median
+580% vs market
20122024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20122024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-07-01 – 2015-12-31
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ET | Audit | 1997 | — | — |
KM Management | Management | 1997 | — | — |
HK Audit | Audit | 1998 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1998 | — | — | |
| Board of Directors | 1997 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 33.3% | 33.3% | 1998 | |
| Individual | 33.3% | 33.3% | 1998 | |
| Individual | 25.0% | 25.0% | 1998 | |
| Individual | 5.0% | 100.0% | 1998 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CHEMVET PHARMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tronborg Andersen | Audit | 0 companies |
| Kim Madsen | Management | 0 companies |
| Hans Kristian Carøe | Audit | 0 companies |
| Joan Kjærgaard Christensen | Board of Directors | 0 companies |
| Per Emil Hasselbalch Stakemann | Board of Directors | 0 companies |